Expert Urological Care & Minimally Invasive MIST Center in Seoul

4.9 Patient Satisfaction

en-US

Straight Urology Clinic LogoStraight Urology Clinic Home
Book Consultation
Book Consultation
Patient Guide
SpecialtiesServicesDoctorsOffersArticlesReviewsAbout UsContact Us
Minimally Invasive BPH Surgery vs Prostate Enucleation

Medical Guide

Minimally Invasive BPH Surgery vs Prostate Enucleation

How minimally invasive BPH procedures compare with prostate enucleation like HoLEP by prostate size, with guidance from Straight Urology Clinic in Seoul.

Schedule a Consultation

Minimally Invasive BPH Surgery vs Prostate Enucleation

Medically reviewed by Dr. Donghyun Lee, MOHW Board-Certified Urologist, Chief Director, Straight Urology Clinic

One of the most important factors in choosing a treatment for an enlarged prostate is the size of the gland: minimally invasive surgical therapies suit smaller and moderate prostates, while enucleation is often preferred for larger ones. Minimally invasive options such as UroLift, Rezūm, and iTind relieve symptoms with limited tissue disruption, whereas enucleation procedures such as holmium laser enucleation of the prostate (HoLEP) remove the obstructing tissue more completely and can be used across a wide range of prostate sizes. Straight Urology Clinic in Seoul, led by Dr. Donghyun Lee, an MOHW board-certified urologist, offers a curative prostate enucleation surgery alongside minimally invasive options. This article explains how the two families of treatment differ, how prostate size guides the decision, and the honest risks of each.

Why Does Prostate Size Shape the Treatment Decision?

Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate that can squeeze the urethra and cause urinary symptoms such as a weak stream, frequency, urgency, waking at night to urinate, and incomplete emptying. As the National Institute of Diabetes and Digestive and Kidney Diseases notes, symptoms do not always track with prostate size, and treatment ranges from watchful waiting and medication to procedures and surgery depending on severity and its impact on quality of life.

When a procedure is warranted, the volume of the prostate becomes a central consideration. Minimally invasive surgical therapies (MIST) are generally designed for smaller and moderate glands, where relieving obstruction with limited tissue disruption is realistic. Larger prostates contain more obstructing tissue, and removing enough of it to durably relieve symptoms often calls for a more definitive operation. This is not a matter of one approach being universally better; it is a matter of matching the tool to the anatomy. A thorough evaluation, including measurement of prostate size, is what makes that match possible, and no single approach is right for every man.

What Are the Minimally Invasive Options?

Minimally invasive surgical therapies aim to relieve BPH symptoms without removing large amounts of tissue and, in many cases, without general anesthesia. UroLift, a prostatic urethral lift, uses small permanent implants to pull enlarged lobes out of the path of urine flow and was FDA-cleared in 2013. Rezūm uses water vapor to shrink obstructing tissue that the body then reabsorbs and was FDA-cleared in 2015. iTind is a temporary implant that reshapes the bladder neck and prostatic urethra over several days before being removed and was authorized through the FDA's De Novo pathway in 2020.

These options are attractive for suitable candidates because they generally involve quicker recovery and a lower risk of certain side effects, particularly changes to ejaculation, than more extensive surgery. However, they are not designed for the largest prostates, they do not cure BPH, and symptoms can persist or recur, meaning retreatment is possible. Their durability continues to be studied, and the benefit for any individual depends on prostate size and shape, symptoms, and overall health. For a deeper comparison of these three specific procedures, discuss them directly with a urologist who has examined you.

What Is Prostate Enucleation, and How Is It Different?

Enucleation is a more complete, tissue-removing approach. Rather than lifting, shrinking, or reshaping tissue, enucleation separates and removes the enlarged inner portion of the prostate, the part causing obstruction, in a way conceptually similar to peeling out the overgrown tissue while leaving the outer capsule intact. Holmium laser enucleation of the prostate (HoLEP) is a well-established enucleation technique that uses an FDA-cleared holmium laser system to perform this removal precisely. HoLEP is a technique rather than a single branded product, and Straight Urology Clinic describes its offering generically as a curative prostate enucleation surgery.

Because enucleation removes obstructing tissue thoroughly, contemporary urology literature describes it as effective across a wide range of prostate sizes, and reviews have referred to laser enucleation as a size-independent option for surgical management of BPH. This is a key contrast with MIST: where minimally invasive procedures leave most tissue in place, enucleation removes the obstructing tissue, which is why it is generally considered for larger glands and for men who want a more definitive result. Enucleation is more involved than an office-based MIST procedure and carries its own recovery and risks, discussed below.

When Does Enucleation Become the Preferred Approach?

Prostate size is often the deciding factor. European Association of Urology guidance recommends enucleation for larger prostates, generally those above about 80 mL, where the traditional operation, transurethral resection of the prostate (TURP), carries more risk because of the greater volume of tissue involved and the longer resection time. In this size range, an enucleation technique such as HoLEP can remove the obstruction more completely while managing the risks that come with larger glands.

TURP remains the long-standing comparator against which newer approaches are measured, and it is still widely used for moderate prostates. For very large glands, however, the balance of evidence has shifted toward enucleation as a way to treat the obstruction thoroughly. The decision is individualized: prostate size is central, but bladder function, symptom severity, other medical conditions, medications such as blood thinners, and a man's own goals all factor in. A urologist weighs these together rather than applying a single rule, and the same size prostate may lead to different recommendations in different men.

How Do Recovery and Risks Compare?

Recovery generally scales with how much is done. Minimally invasive procedures tend to involve shorter recovery, sometimes with a brief period of catheter use, and many men return to normal activities relatively quickly. Enucleation is a more extensive operation, typically involving a hospital stay and a catheter for a period afterward, followed by a recovery during which temporary urinary symptoms are common. In exchange for the greater upfront recovery, enucleation removes more obstructing tissue, which can offer durable relief, though no operation can be promised to work permanently.

Both approaches carry risks that deserve honest discussion. Potential effects after prostate procedures can include temporary urinary symptoms, blood in the urine, urgency or leakage, urinary tract infection, narrowing (stricture) of the urethra or bladder neck, and effects on sexual function. Enucleation, because it removes more tissue, more often causes retrograde ejaculation (semen passing back into the bladder), whereas MIST options more often preserve ejaculation. Temporary urinary incontinence can also occur after enucleation as the area heals. These risks vary by individual and by technique, and your urologist should explain the realistic likelihood for your situation.

How Do the Two Approaches Compare on Durability?

Durability is a genuine differentiator. Because minimally invasive procedures leave most prostate tissue in place, and because BPH is progressive, symptoms can return over time for some men, and retreatment, whether repeating a MIST, adding medication, or moving to a more definitive operation, is possible. Enucleation removes the obstructing tissue, and the urology literature reports long-term durability of outcomes, with low rates of needing repeat surgery over many years. That is part of why enucleation is often described as a more definitive option.

Even so, "more durable on average" is not a guarantee for any individual, and no procedure cures the underlying tendency of the prostate. A satisfactory long-term result for one man does not predict the same for another. The trade-off is real and personal: a less invasive procedure with easier recovery but a higher chance of needing something further later, versus a more involved operation with greater upfront recovery but generally more durable relief. Understanding this trade-off, rather than expecting a permanent fix from any single treatment, keeps expectations aligned with the evidence.

How Is the Right Choice Determined for You?

Choosing between minimally invasive therapy and enucleation is an individualized decision made after examination, not from symptoms alone. The key inputs are prostate size and shape, the severity of your symptoms and how much they affect your life, your bladder function, other medical conditions and medications, and your own priorities, including how you weigh recovery time against durability and how important preserving ejaculation is to you. For a smaller or moderate gland, a MIST option may be very reasonable; for a large gland, enucleation may be the more appropriate route, consistent with EAU guidance.

Straight Urology Clinic offers both minimally invasive options and a curative prostate enucleation surgery, and Dr. Donghyun Lee, a urologist certified by Korea's Ministry of Health and Welfare (MOHW), evaluates each patient before recommending an approach. The clinic's documented one-stop, same-day model allows consultation, examination, and diagnostic assessment to be combined efficiently in many cases, which can help patients traveling from abroad. You can learn more on the Straight Urology Clinic website, and international patients can start an inquiry through the contact page. The clinic is located near Ahyeon Station on Seoul Metro Line 2.

What Should International Patients Keep in Mind?

Because enucleation is a more involved operation than an office-based MIST procedure, it generally requires a longer stay and a more structured recovery, which matters when planning travel. The appropriate timing for flying after any surgical urology procedure is individual and should be confirmed with the treating urologist rather than assumed. Minimally invasive procedures typically allow a shorter recovery window, but even these vary by person and by procedure, so travel plans should stay flexible until a plan is confirmed in person.

Just as important, the decision about which procedure, if any, is appropriate cannot be finalized from abroad. Prostate size and shape, bladder function, and your overall health need to be assessed in person before a recommendation is meaningful. A pre-travel conversation can help set expectations and outline what an evaluation might involve, but candidacy is confirmed by examination. Framing the trip around a diagnosis-first visit, rather than a predetermined operation, protects you from committing to a procedure that may not turn out to be the best fit for your anatomy.

The Bottom Line

  • Prostate size is central: minimally invasive therapies (UroLift, Rezūm, iTind) generally suit smaller and moderate glands, while enucleation is often preferred for larger ones.
  • Enucleation, such as HoLEP using an FDA-cleared holmium laser system, removes obstructing tissue and is described in the literature as effective across a wide range of prostate sizes.
  • EAU guidance favors enucleation for prostates larger than about 80 mL, where TURP, the traditional comparator, carries more risk.
  • MIST offers easier recovery but a higher chance of needing further treatment; enucleation involves more recovery but generally more durable relief. Neither cures BPH or can be guaranteed.
  • The right choice is individualized and determined by an in-person evaluation of prostate size, symptoms, health, and personal priorities.

Frequently Asked Questions

When is BPH surgery actually needed?

Surgery or a procedure is generally considered when symptoms are bothersome despite medication, when medication is not tolerated or preferred, or when complications develop, such as recurrent infections, bladder stones, blood in the urine, or urinary retention. Mild symptoms may only need watchful waiting or medication. A urologist determines whether a procedure is warranted based on your symptoms, examination, and overall health.

Why is enucleation recommended for large prostates?

Larger prostates contain more obstructing tissue, and removing enough of it to durably relieve symptoms is difficult with minimally invasive or purely resective approaches. European Association of Urology guidance recommends enucleation for prostates larger than about 80 mL, where TURP carries more risk. Enucleation removes the obstructing tissue thoroughly and is described in the literature as effective regardless of prostate size.

Is HoLEP the same as a laser "burning" the prostate?

No. Holmium laser enucleation of the prostate (HoLEP) uses an FDA-cleared holmium laser system to precisely separate and remove the enlarged inner tissue of the prostate, rather than simply vaporizing or burning it away. It is a technique for enucleating obstructing tissue, and the removed tissue can also be examined. Your urologist can explain how the specific enucleation approach would apply to you.

Will I lose sexual function after enucleation?

Enucleation removes more tissue than minimally invasive options, so retrograde ejaculation (semen passing back into the bladder) is a common outcome, while erectile function is often preserved. Minimally invasive procedures more often preserve ejaculation. No outcome is guaranteed for any individual, so discuss your priorities with your urologist before deciding.

Can I choose a minimally invasive option even if my prostate is large?

It depends on your anatomy. Minimally invasive therapies are generally designed for smaller and moderate prostates, and they may not durably relieve obstruction in a very large gland. A urologist assesses whether a minimally invasive option is realistic for your prostate size and shape, or whether enucleation would be more appropriate, during an in-person evaluation.

How is the decision between the two made?

The decision is individualized and based on prostate size and shape, symptom severity, bladder function, other medical conditions and medications, and your personal priorities around recovery and sexual function. There is no single best procedure for everyone. A qualified urologist weighs these factors together after examining you and reviewing imaging.

This article is for general educational purposes and is not a self-diagnosis tool or a substitute for individualized medical advice. Candidacy, treatment selection, and expected outcomes for BPH can only be determined through an in-person consultation with a qualified urologist. Always discuss your specific situation with a licensed provider.

More Articles

Continue reading clinical insights and recovery guides from Straight Urology Clinic.

View All
Who Is a Candidate for REZUM Water Vapor Therapy

Who Is a Candidate for REZUM Water Vapor Therapy

Learn who may be a candidate for REZUM Water Vapor Therapy, key eligibility factors, benefits, and what to expect. Explore your treatment options today.

Learn More

Learn More
Why a Urologist's Case Volume Should Matter to You

Why a Urologist's Case Volume Should Matter to You

Surgical case volume is linked to a urologist's experience but never guarantees your outcome. Learn to read reported urology procedure counts critically.

Learn More

Learn More
What AUA Membership Means for Your Urologist Choice

What AUA Membership Means for Your Urologist Choice

Learn what American Urological Association Full Membership actually means, why it is not a board certification, and how to verify an overseas urologist.

Learn More

Learn More

Straight Urology Clinic

Seoul's leading prostate and urinary specialty clinic offering evidence-based diagnostics, minimally invasive MIST procedures (UroLift, Rezum, iTind, HoLEP), and dedicated international patient support near Ahyeon Station.

Treatments

SpecialtiesServicesDoctorsSpecial OffersMedical Articles

Patient Guide

About UsHow It WorksPatient Reviews

Information & Legal

Contact & LocationSite SearchPrivacy PolicyRefund & Cancellation PolicyTerms of Use

© 2026 Straight Urology Clinic. All rights reserved.

Individual clinical outcomes may vary depending on patient condition. Please consult a board-certified urologist for personalized medical advice.